Frontlight ResearchEarly access
Trial site
Hôpital Emile Muller
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Acute myeloid leukaemia1 trial
- Atopic dermatitis (eczema)1 trial
- Bladder cancer1 trial
- Chronic myeloid leukaemia1 trial
- Liver and biliary tract cancer1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Sjögren's disease1 trial
- Phase
- Phase 33 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Amgen1 trial
- Centre Hospitalier Universitaire de Besancon1 trial
- Hoffmann-La Roche1 trial
- Karyopharm Therapeutics Inc1 trial
- OSE Immunotherapeutics1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Enrolling by invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Lung cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026